|
1
|
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
|
N Engl J Med
|
2011
|
28.99
|
|
2
|
Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.
|
Lancet
|
2012
|
5.00
|
|
3
|
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).
|
Lancet
|
2003
|
4.68
|
|
4
|
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.
|
Eur Heart J
|
2005
|
4.46
|
|
5
|
Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
|
Circulation
|
2012
|
4.10
|
|
6
|
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy.
|
Nat Genet
|
2004
|
3.88
|
|
7
|
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
|
Eur Heart J
|
2004
|
2.78
|
|
8
|
Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
|
Circulation
|
2004
|
2.77
|
|
9
|
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.
|
Lancet Neurol
|
2012
|
2.77
|
|
10
|
Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice.
|
Circulation
|
2006
|
2.76
|
|
11
|
Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.
|
J Mol Med (Berl)
|
2004
|
2.68
|
|
12
|
Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients.
|
J Am Coll Cardiol
|
2002
|
2.58
|
|
13
|
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management.
|
Europace
|
2009
|
2.52
|
|
14
|
Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial.
|
Lancet
|
2002
|
2.49
|
|
15
|
Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients.
|
Europace
|
2012
|
2.30
|
|
16
|
Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease.
|
Hum Mutat
|
2003
|
2.24
|
|
17
|
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
|
J Am Coll Cardiol
|
2013
|
2.17
|
|
18
|
Pacemaker channel dysfunction in a patient with sinus node disease.
|
J Clin Invest
|
2003
|
2.14
|
|
19
|
The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol.
|
Eur Heart J
|
2003
|
2.10
|
|
20
|
Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy.
|
Eur Heart J
|
2008
|
2.09
|
|
21
|
Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data.
|
Eur Heart J
|
2007
|
1.98
|
|
22
|
Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).
|
J Am Coll Cardiol
|
2011
|
1.91
|
|
23
|
Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism.
|
Cardiovasc Res
|
2003
|
1.91
|
|
24
|
Outcome parameters for trials in atrial fibrillation: executive summary.
|
Eur Heart J
|
2007
|
1.90
|
|
25
|
Chronic kidney disease in patients with chronic heart failure--impact on intracardiac conduction, diastolic function and prognosis.
|
Int J Cardiol
|
2006
|
1.80
|
|
26
|
Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
|
J Cardiovasc Electrophysiol
|
2007
|
1.79
|
|
27
|
Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome.
|
Circulation
|
2005
|
1.78
|
|
28
|
Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
|
J Cardiovasc Electrophysiol
|
2007
|
1.68
|
|
29
|
Cardiac autonomic dysfunction in Brugada syndrome.
|
Circulation
|
2002
|
1.68
|
|
30
|
Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice.
|
J Am Coll Cardiol
|
2011
|
1.65
|
|
31
|
Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors.
|
Cardiovasc Res
|
2004
|
1.60
|
|
32
|
Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
|
Heart Rhythm
|
2010
|
1.59
|
|
33
|
Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation.
|
Eur Heart J
|
2007
|
1.58
|
|
34
|
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort.
|
Europace
|
2011
|
1.57
|
|
35
|
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey.
|
Eur Heart J
|
2008
|
1.57
|
|
36
|
Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation.
|
Eur J Nucl Med Mol Imaging
|
2006
|
1.55
|
|
37
|
Diastolic isthmus length and 'vertical' isthmus angulation identify patients with difficult catheter ablation of typical atrial flutter: a pre-procedural MRI study.
|
Europace
|
2008
|
1.54
|
|
38
|
Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure.
|
Heart Rhythm
|
2011
|
1.54
|
|
39
|
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial.
|
Eur Heart J
|
2013
|
1.53
|
|
40
|
Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease.
|
J Am Soc Nephrol
|
2006
|
1.51
|
|
41
|
Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up.
|
Heart Rhythm
|
2005
|
1.50
|
|
42
|
Isolated non-compaction cardiomyopathy.
|
Dtsch Arztebl Int
|
2010
|
1.49
|
|
43
|
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.
|
Europace
|
2007
|
1.46
|
|
44
|
Congenital heart defects in adulthood.
|
Dtsch Arztebl Int
|
2011
|
1.45
|
|
45
|
Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study.
|
Europace
|
2009
|
1.45
|
|
46
|
Phytanic acid accumulation is associated with conduction delay and sudden cardiac death in sterol carrier protein-2/sterol carrier protein-x deficient mice.
|
J Cardiovasc Electrophysiol
|
2004
|
1.43
|
|
47
|
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
|
Am Heart J
|
2007
|
1.42
|
|
48
|
Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation.
|
J Am Coll Cardiol
|
2007
|
1.42
|
|
49
|
Baseline characteristics of patients from Poland enrolled in the global registry of patients with recently diagnosed atrial fibrillation (RecordAF).
|
Kardiol Pol
|
2010
|
1.41
|
|
50
|
Physician-induced torsade de pointes--therapeutic implications.
|
Cardiovasc Drugs Ther
|
2002
|
1.40
|
|
51
|
Direct epicardial mapping predicts the recovery of left ventricular dysfunction in chronic ischaemic myocardium.
|
Eur Heart J
|
2004
|
1.39
|
|
52
|
Recommendations for improving the quality of the interdisciplinary medical care of grown-ups with congenital heart disease (GUCH).
|
Int J Cardiol
|
2010
|
1.39
|
|
53
|
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
|
J Pharmacol Exp Ther
|
2002
|
1.39
|
|
54
|
Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice.
|
Cardiovasc Res
|
2003
|
1.39
|
|
55
|
Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L.
|
Proc Natl Acad Sci U S A
|
2002
|
1.37
|
|
56
|
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.
|
Europace
|
2011
|
1.35
|
|
57
|
Dilemmas in the management of atrial fibrillation in chronic kidney disease.
|
J Am Soc Nephrol
|
2008
|
1.30
|
|
58
|
Inhibition of the Na+/Ca2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3.
|
Heart Rhythm
|
2008
|
1.27
|
|
59
|
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
|
J Am Heart Assoc
|
2013
|
1.26
|
|
60
|
Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
|
J Am Coll Cardiol
|
2013
|
1.23
|
|
61
|
The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation.
|
Am J Cardiol
|
2009
|
1.21
|
|
62
|
Usefulness of tissue Doppler imaging for estimation of filling pressures in patients with primary or secondary pure mitral regurgitation.
|
Am J Cardiol
|
2004
|
1.18
|
|
63
|
ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).
|
Europace
|
2012
|
1.18
|
|
64
|
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.
|
Europace
|
2013
|
1.16
|
|
65
|
Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3.
|
Cardiovasc Res
|
2005
|
1.15
|
|
66
|
Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia.
|
Basic Res Cardiol
|
2003
|
1.15
|
|
67
|
Idiopathic left ventricular aneurysm and sudden cardiac death in young adults.
|
Europace
|
2006
|
1.15
|
|
68
|
Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.
|
J Pharmacol Exp Ther
|
2003
|
1.14
|
|
69
|
G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis.
|
J Exp Med
|
2006
|
1.13
|
|
70
|
ICD leads: design and chronic dysfunctions.
|
Pacing Clin Electrophysiol
|
2003
|
1.13
|
|
71
|
Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
|
Herz
|
2005
|
1.10
|
|
72
|
Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results fron the German ICD Registry EURID.
|
Pacing Clin Electrophysiol
|
2003
|
1.08
|
|
73
|
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.
|
Europace
|
2010
|
1.08
|
|
74
|
Tissue Doppler imaging in patients with moderate to severe aortic valve stenosis: clinical usefulness and diagnostic accuracy.
|
Am Heart J
|
2004
|
1.07
|
|
75
|
Usefulness of tissue Doppler imaging for estimation of left ventricular filling pressures in patients with systolic and diastolic heart failure.
|
Am J Cardiol
|
2005
|
1.06
|
|
76
|
Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics.
|
J Mol Med (Berl)
|
2002
|
1.05
|
|
77
|
Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents.
|
Circulation
|
2005
|
1.04
|
|
78
|
Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
|
Thromb Haemost
|
2012
|
1.04
|
|
79
|
Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome.
|
Cardiovasc Res
|
2005
|
1.03
|
|
80
|
Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
|
Cardiovasc Res
|
2010
|
1.03
|
|
81
|
Damage to the esophagus after atrial fibrillation ablation: Just the tip of the iceberg? High prevalence of mediastinal changes diagnosed by endosonography.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.02
|
|
82
|
Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.
|
Europace
|
2009
|
1.01
|
|
83
|
Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.
|
Am Heart J
|
2012
|
1.01
|
|
84
|
Sudden infant death syndrome and long QT syndrome: an epidemiological and genetic study.
|
Int J Legal Med
|
2005
|
1.01
|
|
85
|
Significant gender-related differences in radiofrequency catheter ablation therapy.
|
J Am Coll Cardiol
|
2003
|
1.00
|
|
86
|
Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation.
|
J Cardiovasc Electrophysiol
|
2010
|
1.00
|
|
87
|
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.
|
Eur Heart J
|
2009
|
1.00
|
|
88
|
Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support.
|
Cardiovasc Res
|
2002
|
0.99
|
|
89
|
Absence of pathognomonic or inflammatory patterns in cardiac biopsies from patients with Brugada syndrome.
|
Circ Arrhythm Electrophysiol
|
2008
|
0.99
|
|
90
|
A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA).
|
Eur Heart J
|
2005
|
0.97
|
|
91
|
Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.
|
Nephrol Dial Transplant
|
2009
|
0.96
|
|
92
|
Atrial Arrhythmias in long-QT syndrome under daily life conditions: a nested case control study.
|
J Cardiovasc Electrophysiol
|
2008
|
0.96
|
|
93
|
Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial.
|
Circ Arrhythm Electrophysiol
|
2011
|
0.96
|
|
94
|
Trends in cardiovascular risk factors among patients with coronary heart disease: results from the EUROASPIRE I, II, and III surveys in the Münster region.
|
Dtsch Arztebl Int
|
2012
|
0.96
|
|
95
|
Doppler tissue analysis of mitral annular velocities: evidence for systolic abnormalities in patients with diastolic heart failure.
|
J Am Soc Echocardiogr
|
2003
|
0.96
|
|
96
|
Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
|
Am J Cardiol
|
2008
|
0.95
|
|
97
|
Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
|
J Pharmacol Exp Ther
|
2002
|
0.95
|
|
98
|
PKC delta-induced activation of MAPK pathway is required for bFGF-stimulated proliferation of coronary smooth muscle cells.
|
Cardiovasc Res
|
2005
|
0.95
|
|
99
|
Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment.
|
J Am Coll Cardiol
|
2009
|
0.95
|
|
100
|
Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.
|
J Cardiovasc Pharmacol
|
2004
|
0.94
|
|
101
|
Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure.
|
Int J Cardiol
|
2005
|
0.94
|
|
102
|
Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.
|
Stroke
|
2014
|
0.94
|
|
103
|
Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome.
|
Circulation
|
2004
|
0.93
|
|
104
|
Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF.
|
Circ Heart Fail
|
2013
|
0.93
|
|
105
|
Endocardial mapping of right ventricular outflow tract tachycardia using noncontact activation mapping.
|
J Cardiovasc Electrophysiol
|
2003
|
0.93
|
|
106
|
Clinical assessment of a new real time 3D quantitative coronary angiography system: evaluation in stented vessel segments.
|
Catheter Cardiovasc Interv
|
2006
|
0.93
|
|
107
|
Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
|
Basic Res Cardiol
|
2005
|
0.92
|
|
108
|
Amiodarone-induced pulmonary toxicity--a fatal case report and literature review.
|
Cardiovasc Drugs Ther
|
2013
|
0.92
|
|
109
|
Age and gender related reference values for transthoracic Doppler-echocardiography in the anesthetized CD1 mouse.
|
Int J Cardiovasc Imaging
|
2006
|
0.92
|
|
110
|
Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
|
Am Heart J
|
2013
|
0.91
|
|
111
|
Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions.
|
Eur Heart J
|
2003
|
0.91
|
|
112
|
Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes.
|
Europace
|
2009
|
0.91
|
|
113
|
A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.
|
Eur J Heart Fail
|
2011
|
0.91
|
|
114
|
Catheter ablation of atrial tachycardia due to recipient-to-donor transatrial conduction after orthotopic heart transplantation.
|
Europace
|
2004
|
0.91
|
|
115
|
Regional, age-dependent, and genotype-dependent differences in ventricular action potential duration and activation time in 410 Langendorff-perfused mouse hearts.
|
Basic Res Cardiol
|
2009
|
0.90
|
|
116
|
Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice.
|
J Mol Cell Cardiol
|
2004
|
0.90
|
|
117
|
Reentrant circuits in the canine atrioventricular node during atrial and ventricular echoes: electrophysiological and histological correlation.
|
Circulation
|
2003
|
0.90
|
|
118
|
Safe performance of magnetic resonance imaging on a patient with an ICD.
|
Pacing Clin Electrophysiol
|
2005
|
0.89
|
|
119
|
Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions.
|
Kidney Int
|
2003
|
0.89
|
|
120
|
Doppler echocardiography and tissue Doppler imaging in the healthy rabbit: differences of cardiac function during awake and anaesthetised examination.
|
Int J Cardiol
|
2006
|
0.89
|
|
121
|
Cardiac sympathetic dysfunction in genotyped patients with arrhythmogenic right ventricular cardiomyopathy and risk of recurrent ventricular tachyarrhythmias.
|
J Nucl Med
|
2011
|
0.89
|
|
122
|
Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy.
|
Heart Rhythm
|
2012
|
0.88
|
|
123
|
Cardiac arrhythmias and sudden death in infancy: implication for the medicolegal investigation.
|
Int J Legal Med
|
2006
|
0.88
|
|
124
|
Proarrhythmia in a non-failing murine model of cardiac-specific Na+/Ca 2+ exchanger overexpression: whole heart and cellular mechanisms.
|
Basic Res Cardiol
|
2012
|
0.88
|
|
125
|
Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
|
Can J Cardiol
|
2008
|
0.87
|
|
126
|
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.
|
Thromb Haemost
|
2011
|
0.87
|
|
127
|
Impact of different stages of chronic kidney disease on in-hospital costs in patients with coronary heart disease.
|
Nephrol Dial Transplant
|
2007
|
0.87
|
|
128
|
Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses.
|
Am J Cardiol
|
2006
|
0.87
|
|
129
|
Short QT interval and short QT syndromes.
|
J Cardiovasc Electrophysiol
|
2005
|
0.86
|
|
130
|
Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization.
|
J Cardiovasc Pharmacol
|
2012
|
0.86
|
|
131
|
Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome.
|
J Cardiovasc Electrophysiol
|
2002
|
0.86
|
|
132
|
Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial.
|
Ann Intern Med
|
2013
|
0.86
|
|
133
|
The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2010
|
0.86
|
|
134
|
Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1.
|
Mol Pharmacol
|
2003
|
0.86
|
|
135
|
Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making?
|
J Am Coll Cardiol
|
2005
|
0.86
|
|
136
|
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey.
|
Clin Cardiol
|
2010
|
0.85
|
|
137
|
Transcriptional profiling of ion channel genes in Brugada syndrome and other right ventricular arrhythmogenic diseases.
|
Eur Heart J
|
2008
|
0.85
|
|
138
|
Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator.
|
Europace
|
2007
|
0.85
|
|
139
|
Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial.
|
J Am Heart Assoc
|
2014
|
0.85
|
|
140
|
Prinzmetal angina: ECG changes and clinical considerations: a consensus paper.
|
Ann Noninvasive Electrocardiol
|
2014
|
0.85
|
|
141
|
Molecular mechanisms of inherited ventricular arrhythmias.
|
Herz
|
2002
|
0.85
|
|
142
|
Bradyarrhythmias and conduction blocks.
|
Rev Esp Cardiol (Engl Ed)
|
2012
|
0.84
|
|
143
|
Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repair.
|
Int J Cardiol
|
2013
|
0.84
|
|
144
|
Coincidence of paroxysmal supraventricular tachycardia and panic disorder: two case reports.
|
Ann Gen Psychiatry
|
2010
|
0.84
|
|
145
|
Biochemical mechanisms of hibernation and stunning in the human heart.
|
Cardiovasc Res
|
2002
|
0.84
|
|
146
|
Ischemic preconditioning by unstable angina reduces the release of CK-MB following CABG and stimulates left ventricular HSP-72 protein expression.
|
J Card Surg
|
2005
|
0.84
|
|
147
|
End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.83
|
|
148
|
Paclitaxel and cyclosporine A show supra-additive antiproliferative effects on smooth muscle cells by activation of protein kinase C.
|
Basic Res Cardiol
|
2002
|
0.83
|
|
149
|
T-wave integral: an electrocardiographic marker discriminating patients with arrhythmogenic right ventricular cardiomyopathy from patients with right ventricular outflow tract tachycardia.
|
Europace
|
2012
|
0.83
|
|
150
|
Real-time RT-PCR for gene expression profiling in blood of heart failure patients-a pilot study: gene expression in blood of heart failure patients.
|
Basic Res Cardiol
|
2004
|
0.83
|
|
151
|
Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment.
|
J Am Soc Echocardiogr
|
2006
|
0.83
|
|
152
|
Prevalence and prognostic impact of comorbidities in patients with severe aortic valve stenosis.
|
Clin Res Cardiol
|
2006
|
0.83
|
|
153
|
Ivabradine in patients with inappropriate sinus tachycardia.
|
Naunyn Schmiedebergs Arch Pharmacol
|
2010
|
0.82
|
|
154
|
Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation.
|
Am J Cardiol
|
2007
|
0.82
|
|
155
|
N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
|
J Heart Lung Transplant
|
2006
|
0.82
|
|
156
|
New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
|
J Card Fail
|
2012
|
0.82
|
|
157
|
Antiarrhythmic effects of free polyunsaturated fatty acids in an experimental model of LQT2 and LQT3 due to suppression of early afterdepolarizations and reduction of spatial and temporal dispersion of repolarization.
|
Heart Rhythm
|
2011
|
0.82
|
|
158
|
T wave alternans does not assess arrhythmic risk in patients with Brugada syndrome.
|
Ann Noninvasive Electrocardiol
|
2004
|
0.81
|
|
159
|
Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
|
Europace
|
2013
|
0.81
|
|
160
|
Impact of female gender on frequency of contrast medium-induced nephropathy: post hoc analysis of dialysis versus diuresis trial.
|
J Womens Health (Larchmt)
|
2010
|
0.81
|
|
161
|
Connexin expression patterns in arrhythmogenic right ventricular cardiomyopathy.
|
Am J Cardiol
|
2013
|
0.81
|
|
162
|
Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
|
Expert Opin Pharmacother
|
2013
|
0.81
|
|
163
|
Drugs that interact with cardiac electro-mechanics: old and new targets for treatment.
|
Prog Biophys Mol Biol
|
2008
|
0.81
|
|
164
|
Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers.
|
Basic Res Cardiol
|
2006
|
0.81
|
|
165
|
Stress and high heart rate provoke ventricular tachycardia in mice expressing triadin.
|
J Mol Cell Cardiol
|
2007
|
0.81
|
|
166
|
Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.
|
Heart Rhythm
|
2012
|
0.81
|
|
167
|
Two different therapeutic strategies in ICD lead defects: additional combined lead versus replacement of the lead.
|
J Cardiovasc Electrophysiol
|
2007
|
0.81
|
|
168
|
Risk predictors for adverse outcomes after percutaneous coronary interventions and their related costs.
|
Clin Res Cardiol
|
2008
|
0.81
|
|
169
|
G-CSF therapy reduces myocardial repolarization reserve in the presence of increased arteriogenesis, angiogenesis and connexin 43 expression in an experimental model of pacing-induced heart failure.
|
Basic Res Cardiol
|
2011
|
0.80
|
|
170
|
Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure: incremental prognostic value of QRS duration and a restrictive mitral filling pattern.
|
J Am Coll Cardiol
|
2005
|
0.80
|
|
171
|
Prevalence of supraventricular tachyarrhythmias in a cohort of 115 patients with Brugada syndrome.
|
Ann Noninvasive Electrocardiol
|
2008
|
0.80
|
|
172
|
Body surface potential mapping in patients with Brugada syndrome: right precordial ST segment variations and reverse changes in left precordial leads.
|
Cardiovasc Res
|
2002
|
0.80
|
|
173
|
Complex ventricular arrhythmias in patients after heterotopic heart transplantation.
|
Int J Cardiol
|
2010
|
0.80
|
|
174
|
Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
|
Am Heart J
|
2005
|
0.79
|
|
175
|
Safety of endomyocardial biopsy in patients with arrhythmogenic right ventricular cardiomyopathy: a study analyzing 161 diagnostic procedures.
|
JACC Cardiovasc Interv
|
2011
|
0.79
|
|
176
|
Autonomic dysfunction in patients with Brugada syndrome: further biochemical evidence of altered signaling pathways.
|
Pacing Clin Electrophysiol
|
2011
|
0.79
|
|
177
|
Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial.
|
Int J Cardiol
|
2013
|
0.79
|
|
178
|
Electrocardiographic risk stratification in families with congenital long QT syndrome.
|
Eur Heart J
|
2006
|
0.79
|
|
179
|
New concepts for old drugs to maintain sinus rhythm in patients with atrial fibrillation.
|
Heart Rhythm
|
2007
|
0.79
|
|
180
|
Vascular injury response in mice is dependent on genetic background.
|
Am J Physiol Heart Circ Physiol
|
2005
|
0.79
|
|
181
|
Recurrent syncope triggered by inappropriate sinus tachycardia.
|
Pacing Clin Electrophysiol
|
2004
|
0.78
|
|
182
|
CHADS(2) and CHA(2)DS (2)-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus.
|
Clin Res Cardiol
|
2012
|
0.78
|
|
183
|
Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?
|
Heart Rhythm
|
2006
|
0.78
|
|
184
|
Prognostic value of different laboratory measures of renal function for long-term mortality after contrast media-associated renal impairment.
|
Clin Cardiol
|
2010
|
0.78
|
|
185
|
Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.
|
Clin Cardiol
|
2008
|
0.78
|
|
186
|
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
|
Cardiovasc Ther
|
2013
|
0.78
|
|
187
|
Transgenic model of cardiac rhabdomyosarcoma formation.
|
J Thorac Cardiovasc Surg
|
2008
|
0.78
|
|
188
|
Soluble Flt-1 links microvascular disease with heart failure in CKD.
|
Basic Res Cardiol
|
2015
|
0.78
|
|
189
|
Drug-induced sudden cardiac death.
|
Eur Heart J
|
2005
|
0.78
|
|
190
|
Prognostic value of a restrictive mitral filling pattern in patients with systolic heart failure and an implantable cardioverter-defibrillator.
|
Am J Cardiol
|
2006
|
0.78
|
|
191
|
Functional changes after partial left ventriculectomy and mitral valve repair assessed by gated perfusion SPECT.
|
J Nucl Med
|
2004
|
0.78
|
|
192
|
Effect of ventricular fibrillation duration on the defibrillation threshold in humans.
|
Pacing Clin Electrophysiol
|
2002
|
0.77
|
|
193
|
Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts".
|
Circulation
|
2013
|
0.77
|
|
194
|
Interatrial conduction delay and atrioventricular block due to primary cardiac lymphoma.
|
J Cardiovasc Electrophysiol
|
2005
|
0.77
|
|
195
|
Myocardial perfusion in nonischemic dilated cardiomyopathy with and without atrial fibrillation.
|
J Nucl Med
|
2009
|
0.77
|
|
196
|
Transmitral flow patterns and the presence of chronic kidney disease provide independent and incremental prognostic information in patients with heart failure and systolic dysfunction.
|
J Am Soc Echocardiogr
|
2007
|
0.77
|
|
197
|
Angiotensin II antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial: rationale and study design.
|
Clin Drug Investig
|
2007
|
0.77
|
|
198
|
The Coronary Artery Disease and Renal Failure (CAD-REF) registry: trial design, methods, and aims.
|
Am Heart J
|
2013
|
0.77
|
|
199
|
Partial left ventriculectomy and mitral valve repair: favorable short-term results in carefully selected patients with advanced heart failure due to dilated cardiomyopathy.
|
J Heart Lung Transplant
|
2005
|
0.77
|
|
200
|
Effect of sotalol and acute ventricular dilatation on action potential duration and dispersion of repolarization after defibrillation shocks.
|
J Cardiovasc Pharmacol
|
2003
|
0.77
|
|
201
|
Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells.
|
Basic Res Cardiol
|
2004
|
0.77
|
|
202
|
Gender differences in cardiac arrhythmias.
|
Herz
|
2005
|
0.77
|
|
203
|
The ECG in cardiovascular-relevant animal models of electrophysiology.
|
Herzschrittmacherther Elektrophysiol
|
2013
|
0.77
|
|
204
|
Low-energy electromagnetic fields promote proliferation of vascular smooth muscle cells.
|
Electromagn Biol Med
|
2008
|
0.77
|
|
205
|
ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).
|
Ann Noninvasive Electrocardiol
|
2012
|
0.77
|
|
206
|
Effect of electrode position on the outcome of cardioversion.
|
Card Electrophysiol Rev
|
2003
|
0.77
|
|
207
|
Impact of haemoglobin concentration and chronic kidney disease in patients with coronary heart disease undergoing percutaneous coronary interventions.
|
Nephrol Dial Transplant
|
2007
|
0.76
|
|
208
|
Left bundle branch block in chronic heart failure-impact on diastolic function, filling pressures, and B-type natriuretic peptide levels.
|
J Am Soc Echocardiogr
|
2006
|
0.76
|
|
209
|
Negative T wave in ischemic heart disease: a consensus article.
|
Ann Noninvasive Electrocardiol
|
2014
|
0.76
|
|
210
|
Antiarrhythmic therapy in heart failure.
|
Heart Fail Monit
|
2002
|
0.76
|
|
211
|
Further evidence of a close anatomical relation between the oesophagus and pulmonary veins.
|
Europace
|
2005
|
0.76
|
|
212
|
Catheter ablation of ventricular tachycardia. From indication to three-dimensional mapping technology.
|
Herz
|
2009
|
0.76
|
|
213
|
A NavX guided cryoablation of an accessory pathway in a large coronary sinus diverticulum.
|
J Cardiovasc Electrophysiol
|
2005
|
0.75
|
|
214
|
Evaluation of defibrillation safety margin in modern implantable cardioverter defibrillators after administration of amiodarone.
|
Clin Res Cardiol
|
2011
|
0.75
|
|
215
|
"Zooming in" to new horizons: conduction abnormalities and other research perspectives in atrial fibrillation.
|
Heart Rhythm
|
2009
|
0.75
|
|
216
|
Vasoactive peptides during long-term follow-up of patients after cardiac transplantation.
|
J Heart Lung Transplant
|
2004
|
0.75
|
|
217
|
Quest for the best candidate: how much imaging do we need before prescribing cardiac resynchronization therapy?
|
Circulation
|
2006
|
0.75
|
|
218
|
Should all patients with heart failure and left ventricular dysfunction receive combined CRT-ICD therapy?
|
Nat Clin Pract Cardiovasc Med
|
2007
|
0.75
|
|
219
|
Primary prevention of sudden cardiac death.
|
Heart
|
2006
|
0.75
|
|
220
|
Letter regarding article by McKechnie et al, "prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention".
|
Circulation
|
2005
|
0.75
|
|
221
|
Drug-eluting stents: do we know enough about safety?
|
Circulation
|
2004
|
0.75
|
|
222
|
Direct stenting of native de novo coronary artery lesions with the sirolimus-eluting stent: a post hoc subanalysis of the pooled E- and C-SIRIUS trials.
|
J Am Coll Cardiol
|
2005
|
0.75
|
|
223
|
Indications to implantable cardioverter defibrillator in heart failure patients: a comment on the recently released ESC Guidelines on treatment and diagnosis of heart failure.
|
Eur Heart J
|
2005
|
0.75
|
|
224
|
Lessons learned from neutral ICD trials.
|
Europace
|
2006
|
0.75
|
|
225
|
[Atrial fibrillation: molecular biology bases].
|
Herz
|
2002
|
0.75
|
|
226
|
Microvascular dysfunction in nonfailing arrhythmogenic right ventricular cardiomyopathy.
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.75
|
|
227
|
[Cardiopulmonary resuscitation. Simpler is more effective: the current guidelines].
|
Med Klin (Munich)
|
2003
|
0.75
|
|
228
|
Therapeutic options and heart failure survival score predictability in an academic heart failure center: an analysis of 120 consecutive patients during a 1-year period.
|
Eur J Heart Fail
|
2002
|
0.75
|
|
229
|
Legal implications of pacemaker and defibrillator guidelines.
|
Card Electrophysiol Rev
|
2003
|
0.75
|
|
230
|
Ambulatory and hospital care in the Federal Republic of Germany.
|
Am Heart Hosp J
|
2007
|
0.75
|
|
231
|
Images in cardiology. Cardiac hemangioma.
|
J Am Coll Cardiol
|
2009
|
0.75
|
|
232
|
[German Competence Network on Atrial Fibrillation (AFNET). A nationwide cooperation for better research and patient care].
|
Med Klin (Munich)
|
2006
|
0.75
|
|
233
|
[Reimbursement of patients with acute coronary syndromes in the German diagnosis related groups systems. Part 1: Basics and reimbursement in the case of conservative treatment].
|
Med Klin (Munich)
|
2006
|
0.75
|
|
234
|
A case of paroxysmal supraventricular tachycardia.
|
Pacing Clin Electrophysiol
|
2004
|
0.75
|
|
235
|
Electrical alternans in long QT syndrome resembling a Brugada syndrome pattern.
|
Pacing Clin Electrophysiol
|
2003
|
0.75
|
|
236
|
One‑year follow‑up of the Polish subset of the RecordAF registry of patients with newly diagnosed atrial fibrillation.
|
Pol Arch Med Wewn
|
2013
|
0.75
|
|
237
|
Autonomic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: biochemical evidence of altered signaling pathways.
|
Pacing Clin Electrophysiol
|
2013
|
0.75
|
|
238
|
Direct epicardial mapping can differentiate hibernating from scarred myocardium: a validation study with 18F-FDG-PET.
|
Ann Noninvasive Electrocardiol
|
2002
|
0.75
|
|
239
|
[ICD lead defects: diagnosis and therapeutical options].
|
Herzschrittmacherther Elektrophysiol
|
2009
|
0.75
|
|
240
|
Improving patient access to novel medical technologies in Europe.
|
Eur Heart J
|
2006
|
0.75
|
|
241
|
[Cardiopulmonary resuscitation in 2006: the ABC of resuscitation revised to ACB].
|
Med Klin (Munich)
|
2006
|
0.75
|
|
242
|
[Long QT-syndromes: diagnosis and genetics].
|
Herzschrittmacherther Elektrophysiol
|
2002
|
0.75
|
|
243
|
Predictors of long-term success after catheter ablation of atriofascicular accessory pathways.
|
Heart Rhythm
|
2011
|
0.75
|
|
244
|
Differential diagnosis of "dysphagia" in an elderly woman.
|
Clin Cardiol
|
2002
|
0.75
|
|
245
|
Time dependent changes of arterial distensibility induced by cholesterol and balloon injury in rabbits: an in vivo intravascular ultrasound study.
|
Int J Cardiovasc Imaging
|
2002
|
0.75
|
|
246
|
In vivo recording of monophasic action potentials in awake dogs.
|
Methods
|
2003
|
0.75
|
|
247
|
[Acute coronary syndrome in the German diagnosis-related groups system. 2: Reimbursement of interventional treatment and consequences of the current system].
|
Med Klin (Munich)
|
2006
|
0.75
|
|
248
|
[Brugada syndrome. Current clinical aspects and risk stratification].
|
Herzschrittmacherther Elektrophysiol
|
2002
|
0.75
|
|
249
|
Vascular ligation response is independent of p107: stressing the role of the related p130.
|
Am J Physiol Heart Circ Physiol
|
2003
|
0.75
|
|
250
|
The long QT syndrome: considerations in the athletic population.
|
Curr Sports Med Rep
|
2003
|
0.75
|
|
251
|
[Management of the acute myocardial infarction in the prehospital emergency setting. Reperfusing and antithrombotic therapy].
|
Anasthesiol Intensivmed Notfallmed Schmerzther
|
2008
|
0.75
|
|
252
|
Novel surface ECG criteria for differentiation between left- and right-sided manifest inferoseptal accessory pathways.
|
Int J Cardiol
|
2008
|
0.75
|
|
253
|
Sex differences in absolute myocardial perfusion. Non-invasive H2(15)O-PET in young healthy adults.
|
Nuklearmedizin
|
2016
|
0.75
|
|
254
|
Transgenic model of smooth muscle cell cycle reentry: expression pattern of the collageneous matrix.
|
Cardiovasc Pathol
|
2007
|
0.75
|